Assisted reproductive technologies: Possible risks and complications for mother and child;Geassisteerde voortplantingstechnieken: Mogelijke risico's en verwikkelingen voor moeder en kind

Tijdschrift voor Geneeskunde

Volumn 59, Issue 21, 2003, Pages 1283-1291

  De Sutter, P ^a   Dhont, M ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; CHROMOSOME ABERRATION; CONCEPTION; CONGENITAL MALFORMATION; DISEASE SEVERITY; FERTILIZATION IN VITRO; HOSPITAL ADMISSION; HUMAN; INFECTION; INTRACYTOPLASMIC SPERM INJECTION; MALE INFERTILITY; NEWBORN DEATH; NEWBORN MORBIDITY; OVARY FUNCTION; OVARY HYPERSTIMULATION; PATIENT COUNSELING; PERINATAL DEVELOPMENT; PRACTICE GUIDELINE; REPRODUCTIVE PROCEDURES; REVIEW; RISK ASSESSMENT; SAFETY;

EID: 0242390345     PISSN: 0371683X     EISSN: None     Source Type: Journal    
DOI: 10.2143/TVG.59.21.1001717     Document Type: Review

References (54)

1. Perinatale activiteiten in Vlaanderen 2001. Brussel: Studiecentrum voor Perinatale Epidemiologie, 2001.
2. LEJEUNE B, DE SUTTER P, ed. Jaarverslag 2000. Belgian Register for Assisted Procreation (Belrap), 2000.
3. DELVIGNE A, DEMOULIN A, SMITZ J, et al. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features. Hum Reprod 1993; 8: 1353-1360.
4. GOLAN A, RON-EL R, HERMAN A, SOFFER Y, WEINRAUB Z, CASPI E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Survey 1989; 44: 430-440.
5. SCHENKER JG. Clinical aspects of ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 1999; 85: 13-20.
6. SHER G, ZOUVES C, FEINMAN M, MAASSARANI G. "Prolonged coasting": an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Hum Reprod 1995; 10: 3107-3109.
7. DHONT M, VAN DER STRAETEN F, DE SUTTER P. Prevention of severe ovarian hyperstimulation by coasting. Fertil Steril 1998; 70: 847-850.
8. SOPELAK VM, HODGEN GD. Infusion of gonadotropin-releasing hormone agonist during pregnancy: maternal and fetal responses in primates. Am J Obstet Gynecol 1987; 156: 755-760.
9. PLATTEAU P, GABBE M, FAMELOS M, KOVACS G, HEALY D. Should we still advise infertile couples to use (barrier) contraception before IVF down-regulation? Fertil Steril 2000; 74: 655-659.
10. HARLAP S, OLSON SH, CURTIN JP, et al. Epithelial ovarian carcinoma and fertility of parents. Epidemiology 2002; 13: 59-65.
11. KLIP H, BURGER CW, KENEMANS P, VAN LEEUWEN FE. Cancer risk associated with subfertility and ovulation induction: a review. Cancer Causes Control 2000; 11: 319-344.
12. DESSOLE S, RUBATTU G, AMBROSINI G, et al. Blood loss following noncomplicated transvaginal oocyte retrieval for in vitro fertilization. Fertil Steril 2001; 76: 205-206.
13. VAN OS HC, ROOZENBURG BJ, JANSSEN-CASPERS HA, et al. Vaginal disinfection with povidon iodine and the outcome of in-vitro fertilization. Hum Reprod 1992; 7: 349-350.
14. ROEST J, MOUS HV, ZEILMAKER G, VERHOEFF A. The incidence of major clinical complications in a Dutch transport IVF programme. Hum Reprod Update 1996; 2: 345-353.
15. MASHIACH S, BIDER D, MORAN O, GOLDENBERG M, BEN-RAFAEL Z. Adnexal torsion of hyperstimulated ovaries in pregnancies after gonadotropin therapy. Fertil Steril 1990; 53: 76-80.
16. STRANDELL A, THORBURN J, HAMBERGER L. Risk factors for ectopic pregnancy in assisted reproduction. Fertil Steril 1999; 71: 282-286.
17. ALBAYRAM F, HAMPER UM. First-trimester obstetric emergencies: spectrum of sonographic findings. J Clin Ultrasound 2002; 30: 161-177.
18. ROJANSKY N, SCHENKER JG. Heterotopic pregnancy and assisted reproduction - an update. J Assist Reprod Genet 1996; 13: 594-601.
19. DUMESIC DA, DAMARIO MA, SESSION DR. Interstitial heterotopic pregnancy in a woman conceiving by in vitro fertilization after bilateral salpingectomy. Mayo Clin Proc 2001; 76: 90-92.
20. PEZESHKI K, FELDMAN J, STEIN DE, LOBEL SM, GRAZI RV. Bleeding and spontaneous abortion after therapy for infertility. Fertil Steril 2000; 74: 504-508.
21. HOFMANN GE, GUNDRUM CL, DRAKE LM, BERTSCHE AB. Frequency and effect of vaginal bleeding on pregnancy outcome during the first 3 weeks after positive beta-hCG test results following IVF-ET. Fertil Steril 2000; 74: 609-613.
22. DEROM R, DEROM C, VLIETINCK R, VAN MAELE G, VAN DEN BERGHE H. Twin pregnancies after medically assisted reproduction: epidemiology, comparative perinatal morbidity and mortality. J Perinat Med 1991; 19 Suppl 1: 229-233.
23. COETSIER T, DHONT M. Avoiding multiple pregnancies in in-vitro fertilization: who's afraid of single embryo transfer? Hum Reprod 1998; 13: 2663-2664.
24. DE SUTTER P, COETSIER T, VAN DER ELST J, et al. Elective single embryo transfer in IVF/ICSI: an analysis of 126 cases. Hum Reprod 2000; 15 (Suppl): O-157.
25. DHONT M. Single-embryo transfer. Semin Reprod Med 2001; 19: 251-258.
26. GERRIS J, DE NEUBOURG D, MANGELSCHOTS K, VAN ROYEN E, VAN DE MEERSSCHE M, VALKENBURG M. Prevention of twin pregnancy after in-vitro fertilization or intracytoplasmic sperm injection based on strict embryo criteria: a prospective randomized clinical trial. Hum Reprod 1999; 14: 2581-2587.
27. GERRIS J, DE NEUBOURG D, MANGELSCHOTS K, et al. Elective single day 3 embryo transfer halves the twinning rate without decrease in the ongoing pregnancy rate of an IVF/ICSI programme. Hum Reprod 2002; 17: 2626-2631.
28. CONDE-AGUDELO A, BELIZAN JM, LINDMARK G. Maternal morbidity and mortality associated with multiple gestations. Obstet Gynecol 2000; 95 (6 Pt 1): 899-904.
29. SHERER DM. Adverse perinatal outcome of twin pregnancies according to chorionicity: review of the literature. Am J Perinatol 2001; 18: 23-37.
30. PETTERSON B, BLAIR E, WATSON L, STANLEY F. Adverse outcome after multiple pregnancy. Baillieres Clin Obstet Gynaecol 1998; 12: 1-17.
31. MITTLER P. Language development in young twins: biological, genetic and social aspects. Acta Genet Med Gemellol (Roma) 1976; 25: 359-365.
32. BRYAN EM. The death of a twin. Palliat Med 1995; 9: 187-192.
33. BONDUELLE M, LIEBAERS I, DEKETELAERE V, et al. Neonatal data on a cohort of 2889 infants born after ICSI (1991-1999) and of 2995 infants born after IVF (1983-1999). Hum Reprod 2002; 17: 671-694.
34. BONDUELLE M, VAN ASSCHE E, JORIS H, et al. Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. Hum Reprod 2002; 17: 2600-2614.
35. WENNERHOLM UB, BERGH C, HAMBERGER L, et al. Incidence of congenital malformations in children born after ICSI. Hum Reprod 2000; 15: 944-948.
36. ERICSON A, KALLEN B. Congenital malformations in infants born after IVF: a population-based study. Hum Reprod 2001; 16: 504-509.
37. HANSEN M, KURINCZUK JJ, BOWER C, WEBB S. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med 2002; 346: 725-730.
38. ANTHONY S, BUITENDIJK SE, DORREPAAL CA, LINDNER K, BRAAT DD, DEN OUDEN AL. Congenital malformations in 4224 children conceived after IVF. Hum Reprod 2002; 17: 2089-2095.
39. LUDWIG M, KATALINIC A. Malformation rate in fetuses and children conceived after ICSI: results of a prospective cohort study. Reprod Biomed Online 2002; 5: 171-178.
40. BOWEN JR, GIBSON FL, LESLIE GI, SAUNDERS DM. Medical and developmental outcome at 1 year for children conceived by intracytoplasmic sperm injection. Lancet 1998; 351: 1529-1534.
41. BONDUELLE M, JORIS H, HOFMANS K, LIEBAERS I, VAN STEIRTEGHEM A. Mental development of 201 ICSI children at 2 years of age. Lancet 1998; 351: 1553.
42. SUTCLIFFE AG, TAYLOR B, SAUNDERS K, THORNTON S, LIEBERMAN BA, GRUDZINSKAS JG. Outcome in the second year of life after in-vitro fertilisation by intracytoplasmic sperm injection: a UK case-control study. Lancet 2001; 357: 2080-2084.
43. BONDUELLE M, PONJAERT I, STEIRTEGHEM AV, et al. Developmental outcome at 2 years of age for children born after ICSI compared with children born after IVF. Hum Reprod 2003; 18: 342-50.
44. MANNING M, LISSENS W, BONDUELLE M, et al. Study of DNA-methylation patterns at chromosome 15q11-q13 in children born after ICSI reveals no imprinting defects. Mol Hum Reprod 2000; 6: 1049-1053.
45. Cox GF, BURGER J, LIP V, et al. Intracytoplasmic sperm injection may increase the risk of imprinting defects. Am J Hum Genet 2002; 71: 162-164.
46. MAHER ER, BRUETON LA, BOWDIN SC, et al. Beckwith-Wiedemann syndrome and assisted reproduction technology (ART). J Med Genet 2003; 40: 62-64.
47. ORSTAVIK KH, EIKLID K, VAN DER HAGEN CB, et al. Another case of imprinting defect in a girl with Angelman syndrome who was conceived by intracytoplasmic semen injection. Am J Hum Genet 2003; 72: 218-219.
48. VOGT P, CHANDLEY A, HARGREAVE T, KEIL R, MA K, SHARKEY A. Microdeletions in interval 6 of the Y chromosome of males with idiopathic sterility point to disruption of AZF, a human spermatogenesis gene. Hum Genet 1992; 89: 491-496.
49. DE SUTTER P, DHONT M. Reproductieve geneeskunde en genetica. Tijdschr Geneesk 1997; 53: 1163-1170.
50. KLIP H, BURGER CW, DE KRAKER J, VAN LEEUWEN FE. Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF. Hum Reprod 2001; 16: 2451-2458.
51. MONTGOMERY TR, AIELLO F, ADELMAN RD, et al. The psychological status at school age of children conceived by in-vitro fertilization. Hum Reprod 1999; 14: 2162-2165.
52. GOLOMBOK S, BREWAEYS A, GIAVAZZI MT, GUERRA D, MACCALLUM F, RUST J. The European study of assisted reproduction families: the transition to adolescence. Hum Reprod 2002; 17: 830-840.
53. GOLOMBOK S, MACCALLUM F, GOODMAN E, RUTTER M. Families with children conceived by donor insemination: a follow-up at age twelve. Child Dev 2002; 73: 952-968.
54. CHAN RW, RABOY B, PATTERSON CJ. Psychosocial adjustment among children conceived via donor insemination by lesbian and heterosexual mothers. Child Dev 1998; 69: 443-457.